CIK: 1225755 - Address: C/O Harrow, Inc., 102 Woodmont Blvd, Suite 610, Nashville, TN 37205
24 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret2148313212518459
P%wins100757575756778

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/18/22 20:21
5/17/22
EOLSEvolus, Inc.DEHealthDrugPharmaceutical PreparationsSilvernail Lauren PCAOSee RemaS.m-87112.780-68-33142D
3/10/22 19:23
3/8/22
EOLSEvolus, Inc.DEHealthDrugPharmaceutical PreparationsSilvernail Lauren PCAOSee RemaS-999.730-10-5210D
8/12/21 19:05
8/10/21
EOLSEvolus, Inc.DEHealthDrugPharmaceutical PreparationsSilvernail Lauren PCAOSee RemaS.a-16011.180-14-8166D
8/12/21 18:45
8/10/21
EOLSEvolus, Inc.DEHealthDrugPharmaceutical PreparationsSilvernail Lauren PCAOSee RemaS-16011.180-14-7195D
1/26/21 20:51
1/25/21
EOLSEvolus, Inc.DEHealthDrugPharmaceutical PreparationsSilvernail Lauren PCAOSee RemaS-207.460-3-391D
5/31/19 19:51
5/31/19
EOLSEvolus, Inc.DEHealthDrugPharmaceutical PreparationsSilvernail Lauren PCAOSee RemaS-3513.530-3-927D
5/24/18 19:24
5/22/18
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSilvernail Lauren PCAOCFO,CBOS-8730.250-3-465D
3/23/18 21:12
3/22/18
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSilvernail Lauren PCAOCFO,CBO,S-10630.850-3-568D
3/15/18 20:54
3/13/18
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSilvernail Lauren PCAOCFO,CBO,M.d2258.700265672D
3/15/18 20:54
3/13/18
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSilvernail Lauren PCAOCFO,CBO,S.d-89234.500-26-2672D
3/9/18 20:34
3/7/18
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSilvernail Lauren PCAOCFO,CBO,M.dm1748.700203873D
3/9/18 20:34
3/7/18
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSilvernail Lauren PCAOCFO,CBO,S.dm-64032.000-20-2273D
12/28/17 20:51
12/26/17
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSilvernail Lauren PCAOCFO,CBO,M.d1528.700183667D
11/9/17 19:46
11/7/17
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSilvernail Lauren PCAOCFO,CBO,M.d878.700102649D
11/9/17 19:46
11/7/17
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSilvernail Lauren PCAOCFO,CBO,S.d-26826.830-10-1749D
10/16/17 20:20
10/12/17
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSilvernail Lauren PCAOCFO,CBO,S-29826.670-11-1949D
5/31/17 21:01
5/26/17
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSilvernail Lauren PCAOCFO,CBO,M.d2008.700236360D
5/24/17 21:14
5/22/17
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSilvernail Lauren PCAOCFO,CBO,S-3620.200-2-537D
12/15/14 18:54
12/11/14
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSilvernail Lauren PCAOCFO,SecrP1717.7431716D-41-15-1362-41841597114
5/10/12 21:18
5/8/12
ISTAIsta Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsSilvernail Lauren PCAOCFOM.d7325.020146372185D
8/15/11 16:51
8/11/11
ISTAIsta Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsSilvernail Lauren PCAOCFOP114.2833397D-2030-43-58-44-44-10-106-6-17-1982
5/12/11 20:02
5/10/11
ISTAIsta Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsSilvernail Lauren PCAOCFOM.d1963.1376320094D40517916353121194-4-8-22-57-55
12/11/08 15:52
12/9/08
ISTAIsta Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSilvernail Lauren PCAOCFOP110.62930176543D-88-86-64-46884303421115128338463
5/12/05 18:10
5/12/05
ISTAIsta Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticSilvernail Lauren PCAOCFOP.d387.5415New5D87-47-25-26-23-4-1-421014-18-26

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact